Risk of lymphoma in rheumatoid arthritis decreased by long-term treatment with steroids

Lymphoma :: Risk of lymphoma in rheumatoid arthritis decreased by long-term treatment with steroids

Two years or more of oral steroid treatment decreases the risk of rheumatoid arthritis related lymphoma, according to data presented today at EULAR 2007, the Annual European Congress of Rheumatology, in Barcelona, Spain. Furthermore, these effects were found regardless of when in the course of the disease the steroids were first administered. However, these beneficial effects were not observed if the steroids were taken for less than a two-year period.

Study author Dr Eva Baecklund of Uppsala University Hospital, Sweden, said of the results, ?The pros and cons of corticosteroid treatment in rheumatoid arthritis have been a subject of much debate and long term steroid treatment is often limited as a result of concerns about various side effects. What our data show is a new aspect of steroid treatment. Patients with severe rheumatoid arthritis are at increased risk for malignant lymphomas (cancer in the immune system), but long term steroid treatment may decrease this risk.?

In individuals treated with steroids for over two years, the risk of rheumatoid arthritis-associated lymphomas was significantly reduced (relative risk 0.4; 0.2-0.7), whilst less than two years of steroids yielded no such reduced risk (relative risk 0.9; 0.5-1.5). The most pronounced protective steroidal effect was observed in the diffuse large B-cell lymphoma subtype - the type of lymphoma most commonly associated with RA 1,2,3 with an odds ratio of 0.7 (0.4-1.0).

The study involved 378 patients with rheumatoid arthritis-associated lymphoma identified from the Swedish Hospital Register and the Cancer Register compared with 378 individually matched RA controls, i.e. patients with RA but without lymphoma.

Using data on steroid treatment type and duration along with inflammatory load collected from cases and controls, information on lymphoma type (where observed) was also collected. The lymphoma tissues were obtained from the pathology laboratories and were reclassified according to the most recent lymphoma classification, the World Health Organization classification.4

Interestingly, researchers also compiled information on the duration of RA at initiation of steroid treatment. In this study there was no correlation observed between protective function and length of RA at onset of steroidal treatment. The protective effect was identical in those starting steroid treatment the first five years after onset of RA and in those starting later (relative risk 0.6; 0.3-0.9). Steroid treatment outcome was not associated with the presence of the Epstein-Barr virus in the lymphomas.

These results build on those of a previously published study that reported that orally prescribed and intra-articular (administered within the joint or joint cavity) steroids protect the individual from the development of malignant (actively cancerous) lymphomas in a dose responsive manner.1




(Lymphoma :: Risk of lymphoma in rheumatoid arthritis decreased by long-term treatment with steroids published at SpiritIndia on Thursday, June 14, 2007)

Lymphoma

Search more information on Lymphoma, Lymphoma books

Recently posted related articles on Lymphoma :

1. Lymphoma :: Cancer researchers at the University of Pennsylvania discover what makes lymphomas tick
2. Skin Cancer :: Rates of cutaneous T-cell lymphoma increase over 30 years
3. Lymphoma :: Wilmot Cancer Center Expert to Discuss Lymphoma Research
4. Lymphoma :: Risk of lymphoma in rheumatoid arthritis decreased by long-term treatment with steroids
5. Lymphoma :: Overall survival and length of disease remission with GSK's BEXXAR
6. Lymphoma :: Allos' PDX and Gemcitabine in Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
7. Lymphoma :: Wilmot Cancer Center Scientist gets $1.5M to Advance Lymphoma Research
8. Leukemia :: Childhood leukemia and lymphoma survivors have elevated risk of second cancers
9. Hepatitis C :: Hepatitis C increases risk of non-Hodgkin lymphoma
10. Leukemia :: Risk of second malignant neoplasms after childhood leukemia and lymphoma

Most related articles:

- Lymphoma :: Risk of lymphoma in rheumatoid arthritis decreased by long-term treatment with steroids
- Lymphoma :: Autoimmune diseases linked with Non-Hodgkin’s Lymphoma - 17.2
- Lymphoma :: BiovaxID - Promising for Follicular Lymphoma - 16.1
- Leukemia :: Childhood leukemia and lymphoma survivors have elevated risk of second cancers - 15.2
- Rheumatoid Arthritis :: Disability from long-term rheumatoid arthritis reduced with biologic treatment - 13.9
- Lymphoma :: Response to Glucocorticoids Predicts Survival with CNS Lymphoma - 13.8
- Rheumatoid arthritis :: Glucosamine and Rheumatoid arthritis - 13.4
- Lymphoma :: Wilmot Cancer Center Expert to Discuss Lymphoma Research - 12.4
- Leukemia :: Risk of second malignant neoplasms after childhood leukemia and lymphoma - 12.2
- HIV :: AIDS-related cancers decline with introduction of intense antiretroviral therapy - 12.1


»»   Rheumatoid Arthritis :: Mapping rheumatoid arthritis - first multinational review of RA shows
««   Rheumatoid Arthritis :: One-fifth of patients in drug-free remission following early treatment with Infliximab and Methotrex

Home | Cancer | Therapies | Diet | Herbs | Heart | Skin | Cosmetic Surgery | Arthritis | Allergies | Eyes | GIT | Glossary | List

AYUSH = Ayurveda - Yoga - Unani - Siddha - Homeopathy -- Health articles

The information provided on SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Spirit India comply with the HONcode principles for trustworthy health information.
Health, Business, Science, Sports, Entertainment, Technology
©2002-2009 SpiritIndia.com